• SPOP Molecular Glue Degradation in Melanoma Immunotherapy

  2026-08-30

  The reference study identifies SPOP as a melanoma-promoting E3 ligase that degrades the innate immune sensor STING, thereby limiting interferon signaling. It further shows that SPOP inhibitors can act as molecular glues, redirecting SPOP toward CBX4 and enhancing STING-dependent responses that improve checkpoint blockade and CAR-T treatment in preclinical models.

• YM 58483 (BTP2): SOCE Blocker for Ca2+ Research

  2026-08-29

  YM 58483, also called BTP2, is a store-operated Ca2+ entry inhibitor that suppresses sustained calcium influx through CRAC and TRP channels. Product data report approximately 17 nM inhibition of PHA-induced IL-2 production, while a 2025 salivary-gland study used YM58483 to investigate ORAI2-dependent postirradiation fibrosis.

• Methylprednisolone in Steroid-Induced Bone Loss

  2026-08-28

  Methylprednisolone is more than an inflammation-inducing reagent: it is a translational tool for connecting glucocorticoid receptor biology with osteoclast activity, vascular compromise, and femoral-head preservation. This article interprets a rat model of glucocorticoid-induced osteonecrosis and outlines a practical workflow for mechanistic and translational researchers.

• Oridonin Protects Bone Through MAPK/NF-κB Signaling

  2026-08-28

  The 2023 reference study shows that oridonin counteracts thioacetamide-induced bone injury through a dual mechanism: suppressing osteoclastogenesis via MAPK/NF-κB signaling while restoring osteoblast-associated BMP-2/RUNX2 activity. Its paired osteoclast and osteoblast models provide a useful framework for studying therapies that address both excessive bone resorption and impaired bone formation.

• SD 169: A State-Aware p38 MAPK Assay Strategy

  2026-08-27

  SD 169 (indole-5-carboxamide) is a selective p38α/β inhibitor for dissecting inflammatory, metabolic, and neural signaling. This article explains how activation-loop dephosphorylation findings can improve assay design and interpretation beyond simple pathway inhibition.

• Bufalin: A Degrader-Led Roadmap for TNBC

  2026-08-27

  A translational roadmap for positioning Bufalin as a mechanistically informative cardiotonic steroid in triple-negative breast cancer research, integrating STK33 target degradation, assay design, model selection, competitive differentiation, and practical workflow guidance.

• Bacillus Media Shape γ-Glutamyl Peptide Production

  2026-08-26

  The reference study shows that both Bacillus strain identity and growth-medium composition influence γ-glutamyl peptide production, with hemoglobin hydrolysate generally favoring higher peptide concentrations while brain heart infusion selectively supported detectable glutathione formation. Its main practical contribution is a comparative framework for linking substrate composition, amino-acid availability, bacterial growth, and γ-glutamyltransferase activity in microbial flavor and glutathione metabolism research.

• Forskolin for cAMP-Driven Cell Assays

  2026-08-26

  Forskolin provides a direct route to elevate cAMP, making it useful for pathway perturbation, regenerative cell culture, secretion studies, and inflammation-focused assays. This guide translates its mechanism into practical workflows, dose-finding strategies, and troubleshooting decisions anchored to a corneal epithelial culture study.

• JNK-IN-7 for State-Resolved Apoptosis Assays

  2026-08-25

  JNK-IN-7 enables selective JNK inhibition while preserving a pathway-resolved view of infection-associated apoptosis. This article translates Candida krusei findings into practical assay decisions, including c-Jun phosphorylation, mitochondrial, death-receptor, and innate immune readouts.

• JNK-IN-7: From JNK Mechanism to Translational Insight

  2026-08-25

  A thought-leadership analysis of how JNK-IN-7 can connect covalent kinase biology with infection-associated apoptosis, innate immune signaling, and translational assay design.

• Entinostat (MS-275) for HDAC Research Workflows

  2026-08-24

  Entinostat, also known as MS-275 or SNDX-275, provides a selective class I HDAC platform for connecting histone-acetylation measurements with cancer-cell phenotypes. This guide translates evidence from oncology and axolotl regeneration research into practical assay design, controls, and troubleshooting strategies.

• Toremifene: A Mechanism-First Assay Strategy

  2026-08-24

  Toremifene enables a mechanism-first approach to prostate cancer research by separating estrogen receptor effects from STIM1-dependent calcium and metastatic phenotypes. This article translates recent TSPAN18–STIM1 findings into practical, better-controlled assay decisions.

• CCCP: A Mitochondrial Gradient Stress Test

  2026-08-23

  CCCP (carbonyl cyanide m-chlorophenyl hydrazine) is more than an oxidative phosphorylation uncoupler: it is a controlled perturbation for connecting mitochondrial energetics with live-cell morphology. This article explains how to use and interpret CCCP in morphology-focused biomarker workflows, including urine-derived stem cell research.

• SB203580 in Infection-Driven Lung Inflammation

  2026-08-22

  SB203580 provides a focused way to interrogate p38 MAPK signaling in inflammation linking periodontal infection with COPD-like lung injury. This article translates recent mechanistic findings into practical assay design, pathway readouts, and interpretation safeguards.

• Bedaquiline: From ATP Depletion to Assay Design

  2026-08-21

  Bedaquiline is a diarylquinoline antibiotic whose ATP-synthase mechanism creates distinct experimental signatures in tuberculosis and cancer metabolism models. This guide connects direct bacterial killing with host-directed research and translates the evidence into better assay design.

8594 records 1/573 page Next 12345 下5页 Last page